30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

4Q12 and 2012 Revenue: aap Implantate

€36.4MM (~US $47.9MM), +25% 
- LOQTEQ €2.0 (~US $2.6MM)
- Signed pilot U.S. marketing agreement in 4Q for LOQTEQ plates
- Signed agreement to co-develop bone cement with unnamed global medtech company
- Delayed to 1Q13 commencement of in vivo studies of silver coating technology; consulting with regulatory bodies on CE Mark process for the product, which will have application in trauma and orthopaedics